Early Clearance of PlasmaEpidermal Growth Factor ReceptorMutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA

Post time 2026-7-23 17:07:50

journal：Clinical Cancer Research

Authors：Jhanelle E. Gray; Myung-Ju Ahn; Geoffrey R. Oxnard; Frances A. Shepherd; Fumio Imamura; Ying Cheng; Isamu Okamoto; Byoung Chul Cho; Meng-Chih Lin; Yi-Long Wu; Margarita Majem; Oliver Gautschi; Michael Boyer; Krishna C. Bulusu; Aleksandra Markovets; J. Carl Barrett; Rachel Hodge; Astrid McKeown; Ryan J. Hartmaier; Juliann Chmielecki; Vassiliki A. Papadimitrakopoulou; Suresh S. Ramalingam

Published date：2023-9-1

DOI：10.1158/1078-0432.ccr-22-3146

PDF link：https://aacrjournals.org/clincan ... 184/ccr-22-3146.pdf

Article link：https://doi.org/10.1158/1078-0432.ccr-22-3146

Article Source：American Association for Cancer Research (AACR)。

Remark：

Post time 2026-7-23 17:07:51

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AACR] Early Clearance of PlasmaEpidermal Growth Factor ReceptorMutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AACR] Early Clearance of PlasmaEpidermal Growth Factor ReceptorMutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA Copy